Literature DB >> 5567767

Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

A R Clarkson, M K MacDonald, J J Petrie, J D Cash, J S Robson.   

Abstract

The serum and urine concentrations of fibrin/fibrinogen degradation products (F.D.P.) were estimated in 172 patients with glomerulonephritis. In each case the diagnosis was established on the basis of clinical, renal histological, and ultrastructural findings. Serum F.D.P. concentrations were often raised in all types of glomerulonephritis, though more consistently in active proliferative forms. The urinary concentration provided a reliable and sensitive index of activity, progression, and natural history in proliferative glomerulonephritis. In these forms the urinary F.D.P. content was thought to reflect predominantly lysis of intraglomerular fibrin deposits. In minimal lesion and membranous glomerulonephritis low but abnormal concentrations of urinary F.D.P. were consistently found. It is suggested that in these cases the products are derived from limited proteolysis of fibrinogen filtered through an abnormally permeable basement membrane.Daily measurement of urinary F.D.P. concentration is of potential value in the differential diagnosis of patients with glomerulonephritis and at the same time provides a sensitive assessment of the activity and natural history of proliferative disease.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5567767      PMCID: PMC1800376          DOI: 10.1136/bmj.3.5772.447

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  24 in total

Review 1.  THE COAGULATION PROCESS AND GLOMERULAR DISEASE.

Authors:  P VASSALLI; R T MCCLUSKEY
Journal:  Am J Med       Date:  1965-08       Impact factor: 4.965

2.  Lupus nephritis: a clinical and pathologic study based on renal biopsies.

Authors:  R C MUEHRCKE; R M KARK; C L PIRANI; V E POLLAK
Journal:  Medicine (Baltimore)       Date:  1957-02       Impact factor: 1.889

3.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization.

Authors:  V J Marder; N R Shulman; W R Carroll
Journal:  J Biol Chem       Date:  1969-04-25       Impact factor: 5.157

4.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

5.  Natural history of lipoid nephrosis and of membranous glomerulonephritis.

Authors:  V E Pollak; S Rosen; C L Pirani; R C Muehrcke; R M Kark
Journal:  Ann Intern Med       Date:  1968-12       Impact factor: 25.391

6.  Indomethacin and urinary excretion of fibrinogen-like material in proliferative glomerulonephritis.

Authors:  J Vermylen; G Dotremont; G de Gaetano; M B Donati; P Michielsen
Journal:  Rev Eur Etud Clin Biol       Date:  1970-11

7.  The defibrination syndrome: clinical features and laboratory diagnosis.

Authors:  C Merskey; A J Johnson; G J Kleiner; H Wohl
Journal:  Br J Haematol       Date:  1967-07       Impact factor: 6.998

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Fibrin breakdown products and fibrinolysis in renal disease.

Authors:  E N Wardle; G Taylor
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

10.  Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis.

Authors:  C V Ruckley; P C Das; A G Leitch; A A Donaldson; W A Copland; A T Redpath; P Scott; J D Cash
Journal:  Br Med J       Date:  1970-11-14
View more
  23 in total

Review 1.  Basement membrane.

Authors:  J T Ireland
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 2.  Bright's disease today: the pathogenesis and treatment of glomerulonephritis. 3.

Authors:  J S Cameron
Journal:  Br Med J       Date:  1972-10-28

3.  Serial estimation of urinary fibrin fibrinogen degradation products in kidney transplantation.

Authors:  C L Hall; N Pejhan; R W Thomson; P Dawson-Edwards; A D Barnes; B H Robinson; M J Meynell; J D Blainey
Journal:  Br Med J       Date:  1973-07-28

4.  [Disseminated intravascular coagulation following kidney allotransplantation. Diagnostic significance and therapeutic consequences].

Authors:  V Zühlke; E Quellhorst; E Hierholzer; G Mietzsch
Journal:  Klin Wochenschr       Date:  1972-04-01

5.  Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients admitted to a psychiatric unit.

Authors:  R Hunter; T Thomson; C M Reynolds; P M Pitcher
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

6.  Fibrin-fibrinogen degradation products in children with renal disease.

Authors:  W S Uttley; H Maxwell; J D Cash
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

7.  Urinary FDP in children with renal disease.

Authors:  W Uttley
Journal:  Arch Dis Child       Date:  1973-04       Impact factor: 3.791

8.  Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J D Cash; J S Robson
Journal:  Br Med J       Date:  1972-07-29

9.  Antithrombin III and fibrinogen degradation product (fragment E) in diabetic nephropathy.

Authors:  V Chan; C K Yeung; T K Chan
Journal:  J Clin Pathol       Date:  1982-06       Impact factor: 3.411

10.  Menstrual blood loss and fibrin degradation products.

Authors:  S K Cole; A R Clarkson
Journal:  Br Med J       Date:  1972-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.